Jaroslaw Kociecki

professor

Poznan University of Medical Sciences

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Jaroslaw Kociecki is a faculty member at Poznan University of Medical Sciences in Poland. His research primarily focuses on ocular health, with recent publications addressing topics such as anti-VEGF treatments, the effectiveness of toric lenses, and visual recovery after surgical procedures. Additionally, he has explored the implications of COVID-19 on ophthalmic conditions and advancements in cataract surgery.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (2)

Anna Gotz-Więckowska

Poznan University of Medical Sciences

POLAND

View details

Aleksandra Krasińska-Płachta

Poznan University of Medical Sciences

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jaroslaw Kociecki

Research Interests

Explore related searches

Contact this professor

About

Articles (11)

Rotational stability of the enVista® toric lens compared to other commonly implanted toric intraocular lenses – a literature review

Recovery of visual function after endarterectomy - series of cases report

Visual outcomes in carotid stenosis patients treated using endarterectomy

The Safety of Anti-VEGF Treatment, in the Context of the Retinal Nerve Fibre Layer, in Patients with Wet Age-Related Macular Degeneration: A Review

Diplopia and Optic Disc Edema as the Ocular Manifestations of COVID-19 in a Seven-Year-Old Child

Pomiędzy optyką jednoogniskową a soczewkami EDOF – nowy standard w chirurgii zaćmy z soczewkami monofocal plus?

The outcome of ciliary body ablation with diode laser contact transscleral cyclophotocoagulation in 6 months follow-up.

Aflibercept versus Faricimab in the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Review

Switching Between Aflibercept and Ranibizumab in the Treatment of Refractory Exudative Age-related Macular Degeneration

SMILE – charakterystyka zabiegu i jakość życia pacjentów

Odpowiedni dobór schematu leczenia kluczem do sukcesu terapii wAMD

Collaborators (2)

Anna Gotz-Więckowska

Aleksandra Krasińska-Płachta

Make your next move.